CHRISTINE SMITH: Open Payments
NPI 1760531180 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,335 in 119 payments from 18 companies in 2025. Trend: 2023 $4,190 · 2024 $3,946 · 2025 $2,335
Food & beverage: $2,335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $579 |
| AstraZeneca Pharmaceuticals LP | 11 | $335 |
| Novo Nordisk Inc | 10 | $227 |
| PFIZER INC. | 11 | $192 |
| Teva Pharmaceuticals USA, Inc. | 12 | $185 |
| Phathom Pharmaceuticals, Inc. | 9 | $181 |
| Verona Pharma, Inc. | 13 | $156 |
| LNHC, Inc | 3 | $73 |
| Corcept Therapeutics | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
Products named: UBRELVY, AIRSUPRA, VOQUEZNA, Ohtuvayre, PAXLOVID, AUSTEDO XR, Wegovy, BREZTRI.
Industry payments across ME — which companies pay providers there.
